PharmaTech Insights: Key expert sessions, speaker line up and more
Explore session and speaker spotlights with topics on AI-driven analytics to digital manufacturing solutions, and access the knowledge driving pharmatech's future at Pharmatech Leaders 2026.
Why is LSX Europe moving to Lisbon?
Lisbon is rapidly becoming one of Europe’s most exciting hubs for biotech innovation—making it the perfect backdrop for this year’s LSX World Congress. From its strategic global positioning to its fast-growing scientific and entrepreneurial ecosystem, the city offers unparalleled opportunities for collaboration and discovery. Explore why Lisbon is the ideal home for LSX Europe.
Spotlight Sessions
Leading the Way: How Big Pharma are Responding to the Digital Revolution
How are some pharmaceutical companies at the forefront of digital transformation to accelerate drug discovery? This session which examines how leading pharma companies are adapting to the digital revolution, their implementation strategies, and lessons that can be learned from their successes and challenges.
Clinical Trial Management: The Role of PharmaTech in Successful Clinical Trial Planning
Join this panel session to explore how digital solutions are making clinical trials more efficient, cost-effective, and patient-centred, but also what challenges need to be overcome for its successful implementation.
Rules and Regulations: The Role of Regulatory Bodies in Pharmatech Innovation
Regulatory frameworks significantly impact the pace and direction of digital health adoption. Join this session as an expert panel of speakers examine how regulations influence digital innovation in drug discovery, development, and clinical applications.
Pharmatech Speaker Snapshot
FAQs
What is the focus of the Pharmatech Leaders track?
Pharmatech Leaders addresses the integration of digital technologies, artificial intelligence (AI), and innovation in the pharmaceutical industry. Sessions explore how pharma companies are embracing digital transformation, fostering collaborations with startups, and navigating the evolving landscape of healthcare solutions.
Are there discussions on digital transformation in pharma?
Yes, the agenda includes sessions on how leading pharmaceutical companies are adopting digital strategies to accelerate drug discovery, enhance patient adherence, and improve overall outcomes. These discussions highlight best practices and lessons learned from digital pioneers in the industry.
Are there insights into the adoption of digital health solutions?
Yes, sessions will delve into the differences in digital health adoption between European and American markets. Panels will examine how both regions are embracing digital health technologies, with a focus on the challenges and opportunities presented by these innovations.
Is there a focus on corporate venture capital (CVC) in pharmatech?
Yes, there will be discussions on the role of corporate venture capital in funding pharmatech startups. These sessions provide insights into what CVCs prioritize when evaluating investments, particularly in AI and digital health solutions, and how funding approaches vary based on company size and strategic focus.